 Hello in this video, I want to go through a penny stock that could explode 300% will go through the information in this video that I've got for you today I've got to say I'm not a financial advisor. I'm a business teacher in my daily life But I'm by no means an expert on the stock market What I'm going to do is go through the information that I've got for you in this video and we'll go right into the research I'm really excited about this particular penny stock. I think he's got a lot of potential to run up So I'm really excited about this one. So we'll go through the information. I've got let's get right into it And if you appreciate the direct approach of just getting right into it Then do leave the video like it does help out the channel get right up into that YouTube search results And as a small channel, it really does help out a real lot. So thank you for all the support So let's go into this one. So this is T2 buyer systems. Okay, this is the company T2 buyer systems and who are they who are they so they're a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in health care It's dedicated to improving patient care and reducing the cost of care by helping clinicians efficiently treat patients faster than ever before So it's an industry that is obviously there's a need for these sorts of products and we'll go into some of the products that they have But they do have these ones T2 Biasystem products include the T2 DX instrument T2 T2 candida Panel and T2 bacteria panel and they're powered by the proprietary keyword their proprietary T2 magnetic Resonance Technology so we'll go into this and some of the information that we've got for this stock But it does sound promising. It's actually only sat at $1 81 at the record of this video Okay One of the areas I like to look at when looking at a company is the mission statement or the mission area of the website Because you really get an idea of where they want to go for the future in terms of the future strategy And you can see here some of the missions that they have as a business So he says to T2 by systems are currently targeting a range of critically underserved health care conditions focusing initially on Those with rapid diagnosis that will save an important dual role saving lives and reducing costs Here you've got the first FDA cleared diagnostic panel Here and it's also had over a hundred Studies per published in peer-reviewed journals having featured T2 MR Technology in a breadth of applications now This is important the fact that they've got peer-reviewed studies and a hundred of them That it adds credibility to the business It really does and it can really add to them backing up their claims in terms of what their products can do by having all These peer-reviewed studies and continuing to have those it adds massive credibility to what they're trying to achieve So some of the information here is that there's been a recent actual press release here, and it says that T2 by a systems Actually proves effective amid global rise in variants of the SARS-CoV-2 virus So it's actually interesting in terms of its detection area here so it's a leader in the rapid detection of Sepsis causing pathogens and today it's announced that it's SARS-2 CoV-2 panel a molecule molecular diagnostic test that can detect SARS CoV-2 So this is interesting that they're involved in this area here But also they've got a range of they've got a range of products, right? So investment highlights is a platform technology of multi billion multiple billion dollar franchise opportunities So it's got his T2 platform in terms of innovative technology. It's first in class for some of some of the some of the stuff That he's doing there. So large market two Million dollars initial market potential, which is massive. So there's a lot of market potential for this particular products that they're producing here Reimbursement okay, and then robust pipeline a new generation of diagnostics So they are actually creating a lot of new products and they've got an interest in product portfolio and What I say with any particular business the most Important businesses and the best businesses are ones that have a really good product portfolio And it's execution in terms of it's focused on a US commercial effort Okay, so first in the US and the commercial effort in there We've got to say before we move on to the next part of the video Thank you for everybody for supporting the channel liking the video subscribing to the channel It really does help build up the channel and supporting in getting the channel up there It'd be nice if we could hit 10,000 subscribers at some point I haven't really set a timeframe for it, but it'd just be amazing if we could hit that So if you're new to the channel, please subscribe and also make sure to like the video as well to get it into the YouTube set results. Thank you very much So moving on we'll move on to the information. So we've got a comprehensive product portfolio that is simple to use So you've got three vet free areas here You've got a T2 Candida T2 bacteria and T2 resist resistance here and There's a range of products in the pipeline within this these areas Okay, which is good to see because again, there's potential catalyst with having these products And also is growing independent supporter for T2 Technology, okay, and it represents a substantial clinical improvement over existing technologies in terms of T2 bacteria So you see it's included in dozens of independent real-world clinical cases And it's been granted breakthrough device designation here by a panel So this here is adding to the credibility of this particular company because it's in the health sector Having stuff like the grant granted breakthrough device designation those sorts of areas It just adds credibility to that to what they're doing, right? And credibility is important when it comes to this particular area New U.S. Centers for Medicare and Medicaid Services established T2 bacteria's first diagnostic product again incremental reimbursement Okay, brilliant, and it's been also awarded with up to 69 million dollars in milestone based product development funding So this is brilliant. This is cash that can be used to help develop their products forever and 69 billion 69 million. That's absolutely fantastic And then also it's been awarded innovative technology contracts to T2 buyer systems So essentially there's a lot of stuff going on with this particular business, right? This particular the particular products that they've got here So it's fantastic that this is and there's always some good news coming out about this company which tends to be catalyst for potential Increase in the share price. Okay Now what I want to look at is what are their priorities? Some of the priorities they've got is accelerating sales So again, this is a product that this is a company that is now moving towards more so towards The commercialization and this is where you'll see me find a lot of penny stocks Where it's built the products and the moving towards commercialization Which is a part of the accelerated sales, which is what they're doing, which is a catalyst and then you've got improving in operations Okay, in terms of reducing expenses, which is really important to get those costs down as a business Because it makes sure they have less cash band so to speak to think so they don't burn through as much cash And then they've got an advanced pipeline in terms of they're always developing new products and they've got the current products as well So that pipeline there again involves a lot of catalysts. This is why I think that this stock's got a really good potential And you can look at the revenue here You can see that it's sort of been growing here Well from the in the past we got 2020 and then 19 year in terms of your 5.2 million There's not been growing loads But I mean what I would say is is that there's been you know gradual revenue coming into the business So they are building that revenue here and also they've got cash on hand of 61.8 million So this is in terms of the information that we've got at the moment here Okay, and that's the third quarter of 20 20 5.2 million in revenue And also you can see here some of the information in terms of the stock price forecasts, okay And t2 buyer systems. It's currently at $1 81 Okay, and the actual stock price forecast to five analysts have a target of this much higher Than its current price They've got it at $2 50 on the low the $3 50 on the medium And the five four dollars on the high and it's currently at $1 81 So this stock has got a lot of potential to run up in terms of its current price point So what I'd say it's got a lot of potential in the future in terms of this stock And I think that it's it's a good stock to potentially get into because of all the catalysts that can come with it Okay So what I would say is if you can get this anywhere around $1 61 70 just run a bit of a dip if you can Then that would be good You've seen it pop up here on the 12th of January to $2 nearly $2 20 right On the 12th of January and then it came back down towards $1 80 So it's already popped and then dipped down a bit So it's got a lot of potential here to get into this as it dips because I think that there's catalysts in terms of the products that they're always building the products the building the revenue There's all these areas where there's potential catalysts for the business. Okay, so which is really good to see So I'd consider having this on your watch list consider this for a potential investment And I think that he's got a lot of Great catalysts to come for this business. I want to thank everybody for watching the video And uh subscribing to the channel and liking giving all the support to the channel I really do appreciate it really does help out the channel a lot So thanks for all the support and I will see everybody in the next video